8

 

Structuring the Incentives for Change

 

289

   

 Overview,

 

289

   

 Opportunities for Private Insurers,
Alan Rosenberg

 

290

   

 Opportunities for CMS,
Steve Phurrough

 

295

   

 Opportunities for Pharmaceutical Companies,
Wayne A. Rosenkrans, Jr., Catherine Bonuccelli, and Nancy Featherstone

 

300

   

 Opportunities for Standards Organizations,
Margaret E. O’Kane

 

304

   

 References,

 

313

 

 

APPENDIXES

 

 

A

 

Workshop Agenda

 

315

B

 

Biographical Sketches of Participants

 

321

C

 

Workshop Attendee List

 

345

D

 

IOM Roundtable on Evidence-Based Medicine

 

353



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement